A deep learning model named Sybil can predict future lung cancer risk from a single low-dose chest CT scan, as validated in a large Asian cohort.
Key Details
- 1The Sybil model was validated using data from over 21,000 individuals aged 50-80 who underwent LDCT screening between 2009 and 2021.
- 2Sybil demonstrated strong predictive performance for lung cancer diagnosis both at one and six years following the scan.
- 3The model was effective even for never-smokers, a group for whom conventional screening guidelines may not apply.
- 4The research was presented at the ATS 2025 International Conference.
- 5Continued prospective validation is planned to assess clinical use and prediction of lung cancer-specific mortality.
Why It Matters
This advancement could help tailor lung cancer screening strategies, especially benefiting populations (such as Asian never-smokers) not well-served by current guidelines. A validated AI risk tool from a single scan could make screening more efficient and personalized in routine radiological practice.
Source
EurekAlert
Related News
•EurekAlert
NIH-Backed AI Model Predicts Cancer Survival Using Single-Cell Data
Researchers have developed scSurvival, a machine learning tool that uses single-cell tumor data to accurately predict cancer patient survival and identify high-risk cell populations.
•EurekAlert
Deep Learning Pathomics Platform Improves Immunotherapy Prediction in Lung Cancer
A deep learning pathomics platform accurately predicts immunotherapy response in metastatic NSCLC using routine pathology slides.
•EurekAlert
AI Pathology Model Outperforms PD-L1 in Predicting NSCLC Immunotherapy Response
MD Anderson's Path-IO machine learning platform accurately predicts immunotherapy responses in metastatic non-small cell lung cancer, surpassing current biomarker standards.